---
layout: page
title: Publications
permalink: /publications/
order: 4
---

Rüdesheim S, Wojtyniak JG, Selzer D, Hanke N, Mahfoud F, Schwab M, Lehr T. Physiologically based pharmacokinetic modeling of metoprolol enantiomers and α-hydroxymetoprolol to describe CYP2D6 drug-gene interactions. *Pharmaceutics*. **2020**; 12(12):1200. doi: 10.3390/pharmaceutics12121200. 

Frechen S, Solodenko J, Wendl T, Dallmann A, Ince I, Lehr T, Lippert J, Burghaus R. A generic framework for the physiologically-based pharmacokinetic platform qualification of PK-Sim and its application to predicting cytochrome P450 3A4-mediated drug-drug interactions. *CPT Pharmacometrics Syst Pharmacol*. **2021**; 10(6):633-44. doi: 10.1002/psp4.12636. 

Türk D, Fuhr LM, Marok FZ, Rüdesheim S, Kühn A, Selzer D, Schwab M, Lehr T. Novel models for the prediction of drug-gene interactions. *Expert Opin Drug Metab Toxicol*. **2021**; 17(11):1293-1310. doi: 10.1080/17425255.2021.1998455. 

Rüdesheim S, Selzer D, Fuhr U, Schwab M, Lehr T. Physiologically-based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups. *CPT:PSP*. **2022**; 11(4):494-511. doi: 10.1002/psp4.12776.

Loer HLH, Türk D, Gómez-Mantilla JD, Selzer D, Lehr T. Physiologically based pharmacokinetic (PBPK) modeling of clopidogrel and its four relevant metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 drug–drug–gene interaction predictions. *Pharmaceutics*. **2022**; 14(5):915. doi: 10.1002/psp4.12776. 